Feasibility study of storage concepts for Scout and other NASA solid propellant launch vehicles

Feasibility study of long term storing of Scout and other solid propellant launch vehicles in assembled, flightworthy configuration and facility requirement

Status, Dispersal, and Breeding Biology of the Exotic Eurasian Collared-Dove (Streptopelia decaocto) in Arkansas

The exotic Eurasian Collared-Dove (Streptopelia decaocto) was first sighted in Arkansas at Harrison (Boone Co.) on 25 June 1989. Since this initial sighting the species has grown in numbers and is now present in 42 of 75 counties across the state. In the spring and summer of 2009 and 2010, 20 nests were observed in the urban areas of Fort Smith (Sebastian County). Fifteen of the 20 nests (75%) were located on human-made structures of which 13 (65%) were on an electrical substation and two (10%) were on utility poles. The remaining 5 nests (25%) were in trees. Mean nest height was 7.62 m (n = 20 nests), and the mean width of the nest site support was 40 cm (n = 6 nests). Thirteen of the 20 nests (65%) yielded fledgling(s). Three focal nests were chosen for intense observation. Nest building lasted 1 to 3 days (mean = 2 days); incubation period was 15 days; and fledging occurred 17-18 days after hatching (n = 3 nests). A total of 6 young fledged from these 3 nests

Satellite monitoring of sea surface pollution

There are no author-identified significant results in this report

Information Security as Strategic (In)effectivity

Security of information flow is commonly understood as preventing any information leakage, regardless of how grave or harmless consequences the leakage can have. In this work, we suggest that information security is not a goal in itself, but rather a means of preventing potential attackers from compromising the correct behavior of the system. To formalize this, we first show how two information flows can be compared by looking at the adversary's ability to harm the system. Then, we propose that the information flow in a system is effectively information-secure if it does not allow for more harm than its idealized variant based on the classical notion of noninterference

Birth registration and children's rights: a complex story

Birth registration is a fundamental right of all children and a basic function of all modern governments. So, given the extensive anticipated benefits of birth registration, there has been increasing interest from development organisations in implementing programmes on birth registration in countries with low rates of registration.But there is a significant lack of empirical research that explores the effects of birth registration, and if and how it benefits children in practice.Plan’s new research in India, Kenya, Sierra Leone and Vietnam reveals the results of an investigation into the impact of birth registration. What emerges is a complex picture of the interrelationship between children’s rights and birth registration. As a result, the report makes a series of important recommendations for governments and development partners

Complete Sequence of pSAM7, an IncX4 Plasmid Carrying a Novel bla[sub]CTX-M-14b Transposition Unit Isolated from ' Escherichia coli ' and ' Enterobacter cloacae ' from cattle

The same plasmid carrying blaCTX-M-14b was identified from an Escherichia coli isolate and an Enterobacter cloacae isolate collected from cattle in the United Kingdom by complete plasmid sequencing. This 35,341-bp plasmid, pSAM7, had an IncX4 backbone that is 99% identical to that of pJIE143 from a human isolate in Australia. PCR screening identified pSAM7-like plasmids in three other E. coli isolates of different multilocus sequence types isolated from cattle on different farms in the United Kingdom

The Prevalence of Spent Lead Shot in Wetland Sediments and Ingested by Wild Ducks in Coastal Queensland

Ingestion of spent lead shot by waterfowl, leading to lead poisoning, has been recorded in many parts of the world. In Australia, most attention has been in the southern states where hunting is more popular than elsewhere, and the assumption has been that, except for a few places, the prevalence of lead poisoning is low. To test this assumption, we collected digestive tracts of ducks from four localities and sediments from two wetlands in coastal Queensland where hunting occurs, but where there has been no suggestion that large numbers of birds may be exposed to the possibility of ingesting lead. We found a high prevalence of lead shot in the gut and sediment samples, suggesting that large numbers of birds may be at risk of lead poisoning, and that the prevalence is greater than the state prescribed threshold which would trigger a ban on the use of lead shot at some wetlands

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

BACKGROUND: Despite increasing worldwide use of anti-vascular endothelial growth factor agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular efficacy, the appropriate drug and dose, the need for retreatment, and the possibility of long-term systemic effects. We evaluated the efficacy and safety of intravitreal ranibizumab compared with laser therapy in treatment of ROP. METHODS: This randomised, open-label, superiority multicentre, three-arm, parallel group trial was done in 87 neonatal and ophthalmic centres in 26 countries. We screened infants with birthweight less than 1500 g who met criteria for treatment for retinopathy, and randomised patients equally (1:1:1) to receive a single bilateral intravitreal dose of ranibizumab 0·2 mg or ranibizumab 0·1 mg, or laser therapy. Individuals were stratified by disease zone and geographical region using computer interactive response technology. The primary outcome was survival with no active retinopathy, no unfavourable structural outcomes, or need for a different treatment modality at or before 24 weeks (two-sided α=0·05 for superiority of ranibizumab 0·2 mg against laser therapy). Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT02375971. INTERPRETATION: Between Dec 31, 2015, and June 29, 2017, 225 participants (ranibizumab 0·2 mg n=74, ranibizumab 0·1 mg n=77, laser therapy n=74) were randomly assigned. Seven were withdrawn before treatment (n=1, n=1, n=5, respectively) and 17 did not complete follow-up to 24 weeks, including four deaths in each group. 214 infants were assessed for the primary outcome (n=70, n=76, n=68, respectively). Treatment success occurred in 56 (80%) of 70 infants receiving ranibizumab 0·2 mg compared with 57 (75%) of 76 infants receiving ranibizumab 0·1 mg and 45 (66%) of 68 infants after laser therapy. Using a hierarchical testing strategy, compared with laser therapy the odds ratio (OR) of treatment success following ranibizumab 0·2 mg was 2·19 (95% Cl 0·99-4·82, p=0·051), and following ranibizumab 0·1 mg was 1·57 (95% Cl 0·76-3·26); for ranibizumab 0·2 mg compared with 0·1 mg the OR was 1·35 (95% Cl 0·61-2·98). One infant had an unfavourable structural outcome following ranibizumab 0·2 mg, compared with five following ranibizumab 0·1 mg and seven after laser therapy. Death, serious and non-serious systemic adverse events, and ocular adverse events were evenly distributed between the three groups. FINDINGS: In the treatment of ROP, ranibizumab 0·2 mg might be superior to laser therapy, with fewer unfavourable ocular outcomes than laser therapy and with an acceptable 24-week safety profile. FUNDING: Novartis

In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastoma

\ua9 2024 The Author(s). Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. Background: Medulloblastoma (MB) is the most common malignant pediatric brain tumor, with 5-year survival rates > 70%. Cranial radiotherapy (CRT) to the whole brain, with posterior fossa boost (PFB), underpins treatment for non-infants; however, radiotherapeutic insult to the normal brain has deleterious consequences to neurocognitive and physical functioning, and causes accelerated aging/frailty. Approaches to ameliorate radiotherapy-induced late-effects are lacking and a paucity of appropriate model systems hinders their development. Methods: We have developed a clinically relevant in vivo model system that recapitulates the radiotherapy dose, targeting, and developmental stage of childhood medulloblastoma. Consistent with human regimens, age-equivalent (postnatal days 35-37) male C57Bl/6J mice received computerized tomography image-guided CRT (human-equivalent 37.5 Gy EQD2, n = 12) \ub1 PFB (human-equivalent 48.7 Gy EQD2, n = 12), via the small animal radiation research platform and were longitudinally assessed for > 12 months. Results: CRT was well tolerated, independent of PFB receipt. Compared to a sham-irradiated group (n = 12), irradiated mice were significantly frailer following irradiation (frailty index; P = .0002) and had reduced physical functioning; time to fall from a rotating rod (rotarod; P = .026) and grip strength (P = .006) were significantly lower. Neurocognitive deficits were consistent with childhood MB survivors; irradiated mice displayed significantly worse working memory (Y-maze; P = .009) and exhibited spatial memory deficits (Barnes maze; P = .029). Receipt of PFB did not induce a more severe late-effect profile. Conclusions: Our in vivo model mirrored childhood MB radiotherapy and recapitulated features observed in the late-effect profile of MB survivors. Our clinically relevant model will facilitate both the elucidation of novel/target mechanisms underpinning MB late effects and the development of novel interventions for their amelioration